Hepatitis C virus (HCV) infects over 170 million people worldwide. Chronic infection occurs
in 50–80% of cases and eventually leads to cirrhosis and hepatocellular carcinoma. The …

The Hepatitis C virus is a positive-stranded RNA virus which is the causal agent for a chronic
liver infection afflicting more than 170,000,000 people world-wide. The HCV genome is …

Nonstructural protein 5A of the hepatitis C virus (HCV) is a highly phosphorylated molecule
implicated in multiple interactions with the host cell and most likely involved in RNA …

The hepatitis C virus (HCV) nonstructural protein (NS) 5A is a phosphoprotein that
associates with various cellular proteins and participates in the replication of the HCV …

Replication of the hepatitis C virus (HCV) genome has been proposed to take place close to
the membrane of the endoplasmic reticulum in membrane-associated replicase complexes …

Hepatitis C virus (HCV) infection afflicts more than 170 million people worldwide, with the
great majority of patients with acute hepatitis C developing chronic HCV infection. It can …

Background and aims: There is growing evidence that the response of hepatitis C virus
(HCV) genotype 1b infected patients towards interferon (IFN) therapy is influenced by the …

A significant number of antiviral agents used in clinical practice are amino acids, short
peptides, or peptidomimetics. Among them, several HIV protease inhibitors (eg lopinavir …

Research produces highly efficient antiviral drugs. At the same time, viruses develop
sophisticated strategies to evade their actions. Resistance to antiviral therapy has become a …

Abstract Treatment of hepatocellular carcinoma (HCC) cells with butyrate can induce
apoptosis irrespective of hepatitis B virus integration. No information is available, however …